| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |